Bio-Rad Laboratories (BIO) financials · P/E 43, rev $2.58B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Bio-Rad Laboratories (BIO) P/E 43, rev $2.58B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $2.58B | $2.57B |
| Cost of Revenue | $1.24B | N/A |
| Gross Profit | $1.34B | N/A |
| Operating Income | $47.2M | N/A |
| Net Income | $759.9M | -$1.84B |
| EPS (Diluted) | $27.85 | -$65.36 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $10.58B | $9.36B |
| Current Assets | $2.91B | $3.03B |
| Cash & Equivalents | $529.8M | $488.1M |
| Inventory | $740.7M | $760.0M |
| PP&E | $539.9M | $528.1M |
| Total Liabilities | $3.12B | $2.79B |
| Current Liabilities | $517.0M | $467.8M |
| Long-term Debt | $1.20B | $1.20B |
| Total Debt | $1.21B | $1.20B |
| Shareholders' Equity | $7.45B | $6.57B |
| Retained Earnings | $8.18B | $7.42B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $532.2M | $455.2M |
| CapEx | $157.6M | $165.6M |
| Investing Cash Flow | -$189.7M | -$160.2M |
| Financing Cash Flow | -$283.2M | -$218.8M |
| Net Change in Cash | $42.4M | $85.4M |
| Free Cash Flow | $374.6M | $289.6M |
FAQ
What is BIO P/E and revenue?
Bio-Rad Laboratories (BIO) P/E 43, rev $2.58B.
What is BIO revenue?
Bio-Rad Laboratories last cached revenue is $2.58B (FY2025).
Is BIO profitable?
Bio-Rad Laboratories last cached net income is $759.9M (FY2025).
What are BIO total assets?
Bio-Rad Laboratories last cached total assets are $10.58B (FY2025).
What is BIO free cash flow?
Bio-Rad Laboratories last cached free cash flow is $374.6M (FY2025).
Not investment advice. Cached statements, not a live tape.